Together, these findings indicated that the YAP‐mediated antioxidative capacity plays a crucial role in breast cancer development and it confers clinical impacts of the YAP‐antioxidant axis in obesity‐associated breast cancer. The gene discussed is YAP1; the disease is obesity disorder.